Foundayo (orforglipron) costs $149 a month cash through LillyDirect — no insurance required. That makes Eli Lilly's oral weight-loss pill dramatically cheaper than the injectable brands, which list at $1,000–$1,350/month. If you have coverage, you pay far less: about $50/month on Medicare through the GLP-1 Bridge, or roughly $25/month with commercial insurance that covers weight-loss drugs plus a savings card.
Here's every legitimate way to pay for Foundayo in 2026, what each path actually costs, who qualifies, and how the $149 pill compares to compounded GLP-1s that can run even cheaper.
What does Foundayo cost without insurance?
Without insurance, Foundayo costs $149 per month through LillyDirect, Eli Lilly's own online pharmacy — a flat cash price at any dose. There are no tiered price jumps as you titrate up, which is a real advantage over brand injectables (where higher doses often cost more).
Lilly set this price deliberately low. Because orforglipron is a small-molecule pill rather than a peptide that has to be injected, it's far cheaper to manufacture at scale than semaglutide or tirzepatide — and Lilly priced it to compete directly with cash-pay compounded GLP-1s and to reach the huge market of people without obesity-drug coverage.
How much is Foundayo with commercial insurance?
With commercial insurance that covers Foundayo for weight management, most patients pay around $25/month using Eli Lilly's savings card. The catch is the same one that applies to every weight-loss GLP-1: a large share of employer plans still exclude obesity medications entirely.
If your plan covers it, the savings card brings your copay down to roughly $25. If your plan does not cover weight-loss drugs, the card does little — and the $149 LillyDirect cash price becomes your realistic option (and it's low enough that many people simply pay cash rather than fight a coverage denial). To check, call the number on your insurance card and ask whether Foundayo is on your formulary for chronic weight management.
How much does Foundayo cost on Medicare?
On Medicare, Foundayo costs $50/month through the Medicare GLP-1 Bridge — a federal demonstration that covers Foundayo, Wegovy, and Zepbound for eligible Part D enrollees through December 31, 2027. The $50 copay does not count toward your Part D deductible or your annual out-of-pocket maximum.
To qualify you need a Part D plan and a documented BMI of 30+ (or 27+ with a weight-related condition), plus prior authorization. Full details and the enrollment steps are in our Medicare GLP-1 Bridge guide.
Does Medicaid cover Foundayo?
Medicaid coverage of Foundayo depends on your state — most state Medicaid programs cover GLP-1 medications for obesity, but with prior authorization and BMI requirements. Roughly two-thirds of state programs cover GLP-1s for weight loss; the rest cover them only for diabetes or not at all. Check your state in our Medicaid GLP-1 coverage guide.
Is there a Foundayo coupon or savings card?
Yes — Eli Lilly offers a Foundayo savings card that lowers the copay to about $25/month for commercially insured patients whose plans cover it. As with all manufacturer savings cards, it cannot be used with Medicare, Medicaid, or other government insurance (federal law prohibits it). If you're uninsured or your plan excludes the drug, the LillyDirect $149 cash price is the fallback rather than a coupon.
Foundayo vs compounded GLP-1 cost: which is cheaper?
Foundayo at $149/month is competitive with — but not the cheapest — cash-pay GLP-1. Verified compounded semaglutide starts around $69–$99/month and compounded tirzepatide around $119–$149, all without insurance. The trade-off is format: Foundayo is a brand-name FDA-approved pill, while the compounded options are injectables prescribed by US-licensed telehealth clinicians.
| Path | Monthly cost | Format |
|---|---|---|
| Compounded semaglutide (cheapest) | $69–$99/mo | Injectable |
| Compounded tirzepatide | $119–$149/mo | Injectable |
| Foundayo (orforglipron) | $149/mo cash | Oral pill |
| Foundayo on Medicare Bridge | $50/mo | Oral pill |
| Brand injectables (Ozempic/Wegovy/Zepbound) | $998–$1,350/mo | Injectable |
If a daily pill matters more than saving another $50–$80/month, Foundayo is a strong value. If you're open to injections and want the lowest price — or the most weight loss per dollar (compounded tirzepatide is more effective) — a compounded program usually wins. Compare every verified option on our best GLP-1 providers list and the full GLP-1 Price Index.
How does Foundayo's cost compare to Ozempic, Wegovy, and Zepbound?
Foundayo is roughly 85–90% cheaper than the injectable brands at cash price: $149/month versus $998 for Ozempic, $1,349 for Wegovy, and $1,060 for Zepbound. Even Zepbound's discounted LillyDirect self-pay vials ($349–$499/month) cost more than double Foundayo. The pill's low price is its headline advantage — it delivers less weight loss than tirzepatide, but at a fraction of the cost and with no needles.
Frequently asked questions
How much is Foundayo per month? $149/month cash via LillyDirect with no insurance, $50/month on the Medicare Bridge, or about $25/month with commercial insurance that covers it plus a savings card.
Is Foundayo cheaper than Ozempic or Wegovy? Far cheaper. Foundayo lists at $149/month cash versus $998 (Ozempic) and $1,349 (Wegovy). It's less effective for weight loss than injectable options, but a fraction of the price.
Why is Foundayo so cheap? It's a small-molecule pill, much cheaper to manufacture at scale than injectable peptides, and Lilly priced it aggressively to compete with compounded GLP-1s and reach uninsured patients.
Does insurance cover Foundayo? Some commercial plans do (about $25/month with a savings card); many exclude weight-loss drugs. Medicare covers it at $50/month through the Bridge; Medicaid coverage varies by state.
What's the cheapest way to get Foundayo? If you have Medicare, the $50 Bridge copay. Otherwise, the $149 LillyDirect cash price — or, if you're open to an injection, compounded semaglutide from $69/month can be cheaper overall.
Bottom line
Foundayo's cost is its biggest selling point: $149/month cash undercuts every injectable brand by a wide margin, and Medicare or commercial coverage drops it to $25–$50. It's not the single cheapest GLP-1 — compounded semaglutide starts lower — but it's the cheapest brand-name, FDA-approved option, and the only affordable one in pill form.
If price is your only concern and you'll accept an injection, compare the cheapest verified compounded programs on our best GLP-1 providers list. If you want a pill and $149 works for you, Foundayo is the value pick.